Planta Med 2024; 90(01): 25-37
DOI: 10.1055/a-2180-1338
Biological and Pharmacological Activity
Original Papers

Sargachromenol Attenuates Inflammatory Responses by Regulating NF-κB and Nrf2 Pathways in RAW 264.7 Cells and LPS-treated Mice

Eun-Ji Joung
1   Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea
,
Min-Kyeong Lee
1   Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea
,
Minsup Lee
2   Department of Molecular and Cellular Physiology, Louisiana State University Health Shreveport, Louisiana, United States
,
Misung Gwon
1   Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea
,
Taisun Shin
3   Division of Food and Nutrition, Chonnam National University, Gwangju, Republic of Korea
,
Heeyeon Ryu
1   Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea
,
Hyeon Hak Jeong
4   Department of Smart Green Technology Engineering, Pukyong National University, Busan, Republic of Korea
,
Myeong-Jin Kim
1   Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea
,
Ji Yun Van
4   Department of Smart Green Technology Engineering, Pukyong National University, Busan, Republic of Korea
,
Jae-Il Kim
1   Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea
,
Jinkyung Choi
1   Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea
,
Won-Kyo Jung
5   Division of Biomedical Engineering and Research Center for Marine Integrated Bionics Technology, Pukyong National University, Busan, Republic of Korea
,
Hyeung-Rak Kim
1   Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea
4   Department of Smart Green Technology Engineering, Pukyong National University, Busan, Republic of Korea
,
1   Department of Food Science and Nutrition, Pukyong National University, Busan, Republic of Korea
4   Department of Smart Green Technology Engineering, Pukyong National University, Busan, Republic of Korea
› Author Affiliations

This work was supported by the Korea Institute of Marine Science & Technology Promotion (20220252), Ministry of Oceans and Fisheries, Korea (20210004). This research was supported by a National Research Foundation of Korea (NRF) grant funded by the Ministry of Education (2021R1A6A1A03 039 211).
Preview

Abstract

This study aims to explore the anti-inflammatory mechanisms of sargachromenol in both RAW 264.7 cells and lipopolysaccharide (LPS)-treated mice, as previous reports have suggested that sargachromenol possesses anti-aging, anti-inflammatory, antioxidant, and neuroprotective properties. Although the precise mechanism behind its anti-inflammatory activity remains unclear, pretreatment with sargachromenol effectively reduced the production of nitric oxide, prostaglandin E2, and interleukin (IL)-1β in LPS-stimulated RAW 264.7 cells by inhibiting cyclooxygenase-2. Moreover, sargachromenol inhibited the activation of nuclear factor-κB (NF-κB) by preventing the degradation of the inhibitor of κB-α (IκB-α) and inhibiting protein kinase B (Akt) phosphorylation in LPS-stimulated cells. We also found that sargachromenol induced the production of heme oxygenase-1 (HO-1) by activating the nuclear transcription factor erythroid-2-related factor 2 (Nrf2). In LPS-treated mice, oral administration of sargachromenol effectively reduced the levels of IL-1β, IL-6, and tumor necrosis factor-α (TNF-α) in the serum, suggesting its ability to suppress the production of inflammatory mediators by inhibiting the Akt/NF-κB pathway and upregulating the Nrf2/HO-1 pathway.

Supporting Information



Publication History

Received: 20 April 2023

Accepted after revision: 19 September 2023

Article published online:
17 October 2023

© 2023. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany